MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2023 International Congress

    Longitudinal assessment of evolution and plasma biomarkers for depression and anxiety in Parkinson’s disease

    J. Lin, R. Ou, C. Li, Q. Wei, Y. Hou, L. Zhang, K. Liu, Q. Jiang, T. Yang, Y. Xiao, D. Pang, Y. Yu, B. Zhao, X. Chen, W. Song, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: We aimed to investigatethe evolution of depression and anxietyin a large Parkinson's disease (PD) cohort and explore the related plasma biomarkers. Background: Depression and anxietyare common non-motor…
  • 2023 International Congress

    Hazard ratios of suicidality in a large Huntington disease population compared with controls: marginal structural modeling of Enroll-HD registry data

    S. Reshef, V. Sung, G. Smith, O. Harari, D. Zhang, M. Forrest Gordon, R. Willock, R. Ribalov, J. Robles-Zurita, E. Furr Stimming (Parsippany-Troy Hills, USA)

    Objective: The aim of this study was to describe the risk of suicidality among individuals with versus those without Huntington disease (HD) from Enroll-HD. Background:…
  • 2023 International Congress

    Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: To evaluate the temporality, neuroanatomical correlates and prognostic significance of depression in PD using a large population cohort. Background: Depression may be an important…
  • 2023 International Congress

    Incidence of Parkinson’s disease and modifiable risk factors in Korean population: A longitudinal follow-up study of a nationwide cohort

    SJ. Chung, SH. Kang, S-J. Moon, M. Kang, GJ. Cho, S-B. Koh (Goyang, Republic of Korea)

    Objective: We aimed to investigate the incidence of Parkinson’s disease (PD) by age and year for each sex as well as the modifiable risk factors…
  • 2023 International Congress

    Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders Centers

    C. Marras, D. Weintraub, J. Beck, A. Naito, Z. Meyer, N. Dahodwala, T. Davis, K. Mills, J. Miyasaki, S. Mantri, M. Neault, A. Brown, A. Allen, E. Nelson, H. Liu (Toronto, Canada)

    Objective: Implement depression screening using a validated instrument for people with Parkinson’s (PWP) as part of standard of care in the specialist movement disorders setting…
  • 2023 International Congress

    Risk of Depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population

    F. Hojjati Pour, M. Salari, H. Pakdaman, M. Etemadifar, N. Mirjamali, M. Khalkhali, A. Farahani (Teheran, Islamic Republic of Iran)

    Objective: We aim to evaluate the prevalence of depression in disorders including multiple sclerosis (MS), Parkinson's disease (PD), migraine, and stroke. Also, we detect risk…
  • 2023 International Congress

    Risk factors of sleep disordered breathing in Veterans with Parkinson’s disease.

    A. Sarwar (PEARLAND, USA)

    Objective: To investigate factors associated with the risk of sleep disordered breathing (SDB) in Veterans with Parkinson's disease (PD). Background: Sleep disordered breathing is common…
  • 2023 International Congress

    Angiotensin II Type 1 (AT1) receptor antagonists as potential candidates for anxiety treatment in Parkinson’s Disease

    S. Bordet, L. Grasso, L. Udovin, G. Chevalier, M. Otero-Losada, F. Capani, S. Perez-Lloret (Buenos Aires, Argentina)

    Objective: The aim of this study was to explore the effects of Angiotensin II Type 1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on…
  • 2023 International Congress

    Suicidal ideation and suicide risk in Parkinson’s disease

    J. Lam, X. Tang, D. Meng, J. Zhu, P. Uzelman, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To examine the prevalence of suicidal ideation and suicide risk in patients with Parkinson’s disease (PD) and to assess the relationship between suicidal ideation…
  • 2023 International Congress

    Pain as a Risk Factor for Developing Depression among Patients with Parkinson’s Disease: A Systematic Review of 1426 patients

    S. Mohammed, A. Eldeen (Sohag, Egypt)

    Objective: This systematic review aims mainly to investigate pain as an independent risk factor for developing depressive symptoms among patients with PD. Background: Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley